These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Questions of Safety and Fairness Raised as Right-to-Try Movement Gains Steam. Jacob JA JAMA; 2015 Aug; 314(8):758-60. PubMed ID: 26244653 [No Abstract] [Full Text] [Related]
5. The Right to Try: An Overview of Efforts to Obtain Expedited Access to Unapproved Treatment for the Terminally Ill. Tsakopoulos A; Han J; Nodler H; Russo V Food Drug Law J; 2015; 70(4):617-41. PubMed ID: 26827394 [No Abstract] [Full Text] [Related]
7. Experts critical of America's right-to-try drug laws. Rubin R Lancet; 2015 Oct; 386(10001):1325-6. PubMed ID: 26460764 [No Abstract] [Full Text] [Related]
8. Minnesota's Right to Try law. Hermer LD Minn Med; 2016; 99(1):30-2. PubMed ID: 26897894 [No Abstract] [Full Text] [Related]
9. The Federal Right to Try Act of 2017-A Wrong Turn for Access to Investigational Drugs and the Path Forward. Bateman-House A; Robertson CT JAMA Intern Med; 2018 Mar; 178(3):321-322. PubMed ID: 29356821 [No Abstract] [Full Text] [Related]
11. Unproven stem cell therapies: is it my right to try? Riva L; Campanozzi L; Vitali M; Ricci G; Tambone V Ann Ist Super Sanita; 2019; 55(2):179-185. PubMed ID: 31264641 [TBL] [Abstract][Full Text] [Related]
13. Right-to-try laws and individual patient "compassionate use" of experimental oncology medications: A call for improved provider-patient communication. Hoerger M Death Stud; 2016; 40(2):113-20. PubMed ID: 26313583 [TBL] [Abstract][Full Text] [Related]
14. Currents in contemporary ethics. The implications of expanding access to unapproved drugs. Talbott MK J Law Med Ethics; 2007; 35(2):316-9. PubMed ID: 17518858 [No Abstract] [Full Text] [Related]
15. Right to experimental treatment: FDA new drug approval, constitutional rights, and the public's health. Leonard EW J Law Med Ethics; 2009; 37(2):269-79. PubMed ID: 19493072 [TBL] [Abstract][Full Text] [Related]
16. From bench to FDA to bedside: US regulatory trends for new stem cell therapies. Knoepfler PS Adv Drug Deliv Rev; 2015 Mar; 82-83():192-6. PubMed ID: 25489841 [TBL] [Abstract][Full Text] [Related]
17. Fairer way to distribute last-ditch drugs gets real-world trial. Reardon S Nature; 2016 Jun; 534(7606):160-1. PubMed ID: 27279187 [No Abstract] [Full Text] [Related]
18. What compassionate use means for gene therapies. Chapman CR; Moch KI; McFadyen A; Kearns L; Watson T; Furlong P; Bateman-House A Nat Biotechnol; 2019 Apr; 37(4):352-355. PubMed ID: 30940936 [No Abstract] [Full Text] [Related]
19. Expanded Access to Investigational Drugs: What Physicians and the Public Need to Know about FDA and Corporate Processes. Finkelstein PE AMA J Ethics; 2015 Dec; 17(12):1142-6. PubMed ID: 26698587 [No Abstract] [Full Text] [Related]